KKR to buy Pfizer's capsule unit for $2.4bn
Pfizer has agreed to sell its Capsugel business to private equity group KKR for $2.375bn in cash, in a move analysts said could be the first in a series of spin-offs and sales
Source: FT.com - Pharmaceuticals